Loading...
Loading...
India's aspirin imports from SOUTH AFRICA total $83 across 3 shipments from 2 foreign suppliers. PHARMA DYNAMICS (PTY) LTD leads with $83 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for aspirin โ a concentrated sourcing relationship with select suppliers from SOUTH AFRICA.

PHARMA DYNAMICS (PTY) LTD is the leading Aspirin supplier from SOUTH AFRICA to India, with import value of $83 across 1 shipments. The top 5 suppliers โ PHARMA DYNAMICS (PTY) LTD, ADCOCK INGRAM HEALTHCARE PTY LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMA DYNAMICS (PTY) LTD | $83 | 1 | 100.0% |
| 2 | ADCOCK INGRAM HEALTHCARE PTY LIMITED | $0 | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $83 | 1 | 100.0% |
| 2 | ADCOCK INGRAM LIMITED | $0 | 2 | 0.0% |
Visual overview of India's aspirin SOUTH AFRICA to India import corridor โ top suppliers, destinations, pricing, and trade routes
SOUTH AFRICA โ India trade corridor intelligence
The South Africa to India trade corridor has experienced stable conditions between 2025 and 2026. Port congestion at major Indian ports such as Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra has been minimal, facilitating efficient logistics. Freight rates have remained consistent, and the exchange rate between the Indian Rupee (INR) and South African Rand (ZAR) has been favorable for trade.
The Production Linked Incentive (PLI) scheme, introduced to promote domestic manufacturing, may impact the volume of finished formulation imports from South Africa. Import substitution policies aim to reduce dependency on imports; however, the unique formulations and quality of South African products continue to make them attractive to Indian buyers.
India and South Africa have established a strong trade relationship, with agreements facilitating pharmaceutical trade, including mutual recognition of Good Manufacturing Practices (GMP). These agreements aim to streamline the import process, enhance trade relations, and ensure the quality of pharmaceutical products exchanged between the two nations.
The landed cost of importing finished pharmaceutical formulations containing Aspirin from South Africa to India includes the following components:
Per-unit estimates can be calculated by summing these components and dividing by the total number of units imported.
CDSCO registration, import licensing, and quality testing requirements
Importing finished pharmaceutical formulations containing Aspirin into India requires compliance with the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) mandates that both the drug and the manufacturing site be registered. For new drugs, approval under Rule 122E is necessary before applying for registration or import. Applications for registration and import should be submitted to the Licensing Authority, the Drugs Controller General (India), at the CDSCO office.
Imported pharmaceutical formulations containing Aspirin must undergo quality testing at CDSCO-approved laboratories. Batch-wise testing is required, with each batch accompanied by a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, adhering to ICH Zone IV guidelines, must be provided. Port inspections by customs drug inspectors are conducted to ensure compliance with these standards.
Between 2024 and 2026, the CDSCO has implemented regulatory updates affecting the import of finished pharmaceutical formulations. The Production Linked Incentive (PLI) scheme has been introduced to encourage domestic manufacturing, potentially impacting the volume of finished formulation imports. Bilateral agreements between India and South Africa have been established to facilitate pharmaceutical trade, including mutual recognition of Good Manufacturing Practices (GMP). These agreements aim to streamline the import process and enhance trade relations.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 10%
India imports finished Aspirin formulations to meet domestic demand for patented and branded products, as well as specific dosage forms not produced locally. The domestic pharmaceutical industry has the capacity to manufacture standard Aspirin formulations; however, imports are necessary to fulfill niche market requirements. The market size for Aspirin formulations in India is substantial, with a total export market of $37.8 million across 327 exporters to 121 countries.
The Basic Customs Duty (BCD) for finished pharmaceutical formulations containing Aspirin (HS Code 30049062) is 10%. Additional taxes include the Social Welfare Surcharge (SWS) at 10% and the Integrated Goods and Services Tax (IGST) at 12%. These duties are standard for imports from all countries, including South Africa. Exemptions or concessional rates may apply under specific Free Trade Agreements (FTAs) or bilateral agreements. The total landed duty percentage is calculated by summing the BCD, SWS, and IGST.
India sources finished Aspirin formulations from South Africa due to the availability of patented formulations, specialized dosage forms, and high-quality products. South African manufacturers offer unique formulations not produced domestically, providing a competitive advantage. Other suppliers include China, Germany, and the United States; however, South Africa's share in the Indian market is notable due to these factors.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports finished Aspirin formulations from South Africa due to the availability of patented formulations, specialized dosage forms, and high-quality products not produced domestically. South African manufacturers offer unique formulations that cater to specific market needs in India, providing a competitive advantage.
Compared to other origins such as China, the European Union, and the United States, South Africa offers competitive pricing, high-quality products, and compliance with international regulatory standards. The unique formulations and specialized dosage forms available from South African manufacturers provide a distinct advantage in the Indian market.
Potential risks for Indian importers include single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. While past shortages have been minimal, it is advisable for importers to monitor these risks and develop contingency plans.
Import license checklist, document requirements, quality testing, and compliance
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Aspirin suppliers from SOUTH AFRICA to India include PHARMA DYNAMICS (PTY) LTD, ADCOCK INGRAM HEALTHCARE PTY LIMITED. The leading supplier is PHARMA DYNAMICS (PTY) LTD with import value of $83 USD across 1 shipments. India imported Aspirin worth $83 USD from SOUTH AFRICA in total across 3 shipments.
India imported Aspirin worth $83 USD from SOUTH AFRICA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Aspirin sourced from SOUTH AFRICA include MSN LABORATORIES PRIVATE LIMITED, ADCOCK INGRAM LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $83 in imports across 1 shipments.
The total value of Aspirin imports from SOUTH AFRICA to India is $83 USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists